Leading the way to safer medication
 Crosscheck  Recommender

HYALASE Powder for solution for injection/infusion (2015)

Active ingredients: Hyaluronidase

Product Name and Form

Hyalase 1500 I.U. Powder for Solution for Injection/Infusion or Hyaluronidase 1500 I.U. Powder for Solution for Injection/Infusion

Pharmaceutical form

Powder for solution for injection/infusion.

A white, sterile freeze-dried powder for solution for injection or infusion.

Qualitative and Quantitative Composition

Each ampoule contains 1,500 international units of Hyaluronidase.

For excipients, see section 6.1.

Chemical substance
Description
Hyaluronidase

Hyaluronidase is an enzyme that has a temporary and reversible depolymerising effect on the polysaccharide hyaluronic acid, which is present in the intercellular matrix of connective tissue.

List of excipients

None.

Pack sizes and Marketing

1ml neutral glass ampoule containing a plug of white freeze-dried powder.

Pack size: 10 ampoules.

Marketing authorization holder
Authorization dates

Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF

5th February 1993

Marketing authorization number:

UK: PL 29831/0113

Malta: MA 154/01701